Search

Your search keyword '"Harper, Pg"' showing total 209 results

Search Constraints

Start Over You searched for: Author "Harper, Pg" Remove constraint Author: "Harper, Pg"
209 results on '"Harper, Pg"'

Search Results

1. EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

Catalog

Books, media, physical & digital resources

3. ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

4. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

5. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A phase III trial of the gynecologic cancer intergroup

6. Paclitaxel and cisplatin in ovarian cancer

20. A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

23. Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.

24. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

26. A Quality Improvement Project on Team-Based Care for Depression Screening Before and During the COVID-19 Pandemic in a Specialty Clinic.

27. Harmonizing the Tripartite Mission in Academic Family Medicine: A Longitudinal Case Example.

28. Team-based care: an expanded medical assistant role - enhanced rooming and visit assistance.

29. Lean Implementation for Graduating Optimally Controlled Stable Type 2 Diabetics from Endocrine Specialty Clinic Back to Primary Care.

30. The Nitrogen Mustards.

31. Shared Language for Shared Work in Population Health.

32. The Impact of COVID-19 Proactive Outreach With Somali Seniors.

33. Team-based approach to improving medication reconciliation rates in family medicine residency clinics.

34. Financial Impact of Universal Precepting in Family Medicine Residency Clinics.

35. Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence.

36. Community-based participatory research to decrease smoking prevalence in a high-risk young adult population: an evaluation of the Students Against Nicotine and Tobacco Addiction (SANTA) project.

37. Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

38. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.

39. A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.

40. Bisphosphonate use in patients with lung cancer and bone metastases: recommendations of a European expert panel.

41. A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract.

42. Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.

44. A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer.

45. Chemotherapy for the treatment of hormone-refractory prostate cancer.

46. Adjuvant chemotherapy in non-small cell lung cancer.

47. Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction.

48. Vinorelbine: friend or foe?

49. The management of PS2 patients with advanced non-small cell lung cancer.

50. Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.